• SARC MedIQ is a leading US-based provider of imaging workflow solutions to over 300 healthcare facilities
• Reseller agreement provides EchoIQ immediate access to SARC MedIQ's network and sales force to fast-track EchoSolv AS adoption
• EchoIQ to receive fee per scan, renegotiated higher upon receipt of Category III and Category 1 CPT codes

EchoIQ Limited (ASX:EIQ) has entered into a reseller agreement with leading US-based AI-imaging platform provider, SARC MedIQ to considerably expand the use of EchoSolv AS through an extensive network of hospitals and cardiology practices in the US. SARC MedIQ has over 20 years of combined medical software development experience and provides a unique partnership-based PACS solution to over 300 healthcare facilities, catering to over 1,500 physicians, including a large number of cardiologists. As part of the agreement, SARC MedIQ will act as a reseller of EchoSolv AS to its existing healthcare facilities, which include university hospitals and other large multi-clinic sites. SARC MedIQ will also utilize the solution to drive new business growth and further expand its reach into US hospitals and clinics. EchoIQ will receive payment on a per scan basis from hospitals and clinics that integrate from SARC MedIQ's network. The agreement builds on EchoIQ's recent partnership and integration agreements with ScImage and MedAxiom, which have provided the company with an expanded distribution footprint to demonstrate EchoSolv AS' ability to enhance detection rates for severe Aortic Stenosis.

EchoIQ will receive a fee per scan from hospitals and clinics in the SARC MedIQ network, which will be renegotiated higher upon receipt of Category III CPT code and Category 1 CPT code, with both payments in line with previous guidance provided to the market.

The agreement is expected to considerably reduce EchoIQ's sales and distribution costs, provide faster market access and scale across the US, and has the potential to provide a predictable and ongoing revenue stream in the coming quarters.